Found 7 matching trials
A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC) PHASE4 This is an efficacy and safety study to compare aprepitant with ondansetron...
Show More Location
Multiple Locations
Learn More & Join Trial
Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis NA The purpose of this study is to determine how automated recommendations are...
Show More Location
Vanderbilt University Medical Center
Learn More & Join Trial
Effects of Ondansetron, Metoclopramide and Granisetron on Perioperative Nausea and Vomiting in Patients Undergone Bariatric Surgery PHASE3 Post-operative nausea and vomiting (PONV) is one of the leading causes of p...
Show More Location
Loghman Hakim Hospital
Learn More & Join Trial
Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer PHASE4 Primary Objective:
To assess the tolerability of cabazitaxel 25 mg per bod...
Show More Location
Investigational Site Number 392004
Learn More & Join Trial
Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP NA The incidence and severity of chemotherapy-induced nausea and vomiting (CIN...
Show More Location
Multiple Locations
Learn More & Join Trial
Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer. PHASE4 This is a prospective, multicenter, open label, non-comparative trial in Sp...
Show More Location
Corporació Sanitaria Parc Taulí
Learn More & Join Trial
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031) PHASE3 This study aims to demonstrate that, when given concomitantly with a 5-hydr...
Show More Location
Multiple Locations
Learn More & Join Trial